Literature DB >> 10895367

Interferon gamma and tumor necrosis factor alpha induce Fas expression and anti-Fas mediated apoptosis in a salivary ductal cell line.

R Matsumura1, K Umemiya, T Goto, T Nakazawa, K Ochiai, M Kagami, H Tomioka, E Tanabe, T Sugiyama, M Sueishi.   

Abstract

BACKGROUND: We previously reported that Fas antigen was strongly expressed on salivary duct epithelial cells and that some salivary infiltrating cells showed the Fas ligand in patients with severe sialoadenitis due to Sjögren's syndrome (SS). Apoptotic changes were observed in ductal epithelial cells and some infiltrating cells by DNA nick end labeling methods. These findings suggest that the Fas-Fas ligand system may play a role in the pathogenesis of sialoadenitis in SS.
OBJECTIVE: To elucidate the mechanism of the de novo expression of ductal Fas antigen in sialoadenitis associated with SS, we investigated the induction of Fas antigen and apoptosis by cytokines in a human salivary duct cell line.
METHODS: Human salivary duct cell line (HSG) was cultured with interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin 4 (IL-4), and granulocyte monocyte colony stimulating factor (GM-CSF). The expression of Fas antigen in HSG was examined by immunoperoxidase cell ELISA. The appearance of DNA strand breaks during apoptosis induced by anti-Fas antibody was detected by DNA nick end labeling methods.
RESULTS: Unstimulated HSG cells constitutively expressed low levels of Fas antigen. IFN-gamma and TNF-alpha consistently upregulated constitutive levels of Fas. In contrast, IL-1 beta, IL-2, IL-4, and GM-CSF had no effect on Fas levels. HSG cells expressing Fas antigen in response to IFN-gamma or TNF-alpha were susceptible to apoptosis by anti-Fas antibody.
CONCLUSION: Our findings suggest that IFN-gamma or TNF-alpha secreted by infiltrating lymphocytes induces ductal Fas expression and ductal apoptosis in sialoadenitis associated with SS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10895367

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  14 in total

1.  P2Y2 nucleotide receptor activation up-regulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line.

Authors:  Olga J Baker; Jean M Camden; Danny E Rome; Cheikh I Seye; Gary A Weisman
Journal:  Mol Immunol       Date:  2007-06-27       Impact factor: 4.407

2.  Treating Sjögren's Syndrome: Insights for the Clinician.

Authors:  Claudio Vitali; Gianluigi Palombi; Pierluigi Cataleta
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346

Review 3.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

Review 4.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

5.  Identification of tumor associated single-chain Fv by panning and screening antibody phage library using tumor cells.

Authors:  Yong-Zhan Nie; Feng-Tian He; Zhi-Kui Li; Kai-Chun Wu; Yun-Xin Cao; Bao-Jun Chen; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.

Authors:  Jing Zhou; Jun-O Jin; Ekta S Patel; Qing Yu
Journal:  Cytokine       Date:  2015-08-05       Impact factor: 3.861

7.  Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line.

Authors:  Olga J Baker; Jean M Camden; Robert S Redman; Jonathan E Jones; Cheikh I Seye; Laurie Erb; Gary A Weisman
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-03       Impact factor: 4.249

Review 8.  The future of biologic agents in the treatment of Sjögren's syndrome.

Authors:  Jiska M Meijer; Justin Pijpe; Hendrika Bootsma; Arjan Vissink; Cees G M Kallenberg
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 9.  Interferons in Sjögren's Syndrome: Genes, Mechanisms, and Effects.

Authors:  He Li; John A Ice; Christopher J Lessard; Kathy L Sivils
Journal:  Front Immunol       Date:  2013-09-20       Impact factor: 7.561

10.  Interferon-γ induces immunoproteasomes and the presentation of MHC I-associated peptides on human salivary gland cells.

Authors:  Martha E Arellano-Garcia; Kaori Misuno; Simon D Tran; Shen Hu
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.